🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Acute Leukemia, High Risk

Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention NCT06686108Phase 21 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Azacitidine (AZA) Days 1 - 5, Decitabine (DAC), Venetoclax Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse NCT06928662Phase 1, Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy, Chest Radiography, Cytarabine Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT00801489Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cytarabine, Decitabine, Filgrastim-sndz, Fludarabine Phosphate, Gemtuzumab Ozogamicin HVA vs IA/DA or VA in the Treatment of ND HR-AML NCT06810791Phase 31 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: HVA, VA, Standard Chemotherapy Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia NCT03136146Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Bortezomib, Clofarabine, Cyclophosphamide, Dexamethasone, Etoposide Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML. NCT06483906Phase 21 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Venetoclax, Azacitidine and Homoharringtonine A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. NCT04275518Phase 114 sites📍 Beijing📍 Guangzhou📍 Guangzhou Ascentage Pharma Group Inc. · Tests: APG-115, Azacitidine, Cytarabine Orphan Indications for CD19 Redirected Autologous T Cells NCT04276870Phase 21 site📍 Philadelphia Stephan Grupp MD PhD · Tests: Murine CART19 Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT NCT04746209Phase 21 site📍 Milwaukee Medical College of Wisconsin · Tests: Alpha/Beta T-cell and B-cell depleted HCT, Blinatumomab Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites📍 San Francisco📍 Aurora📍 Atlanta Andrew E. Place, MD · Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS NCT04708054Phase 2, Phase 31 site📍 Houston M.D. Anderson Cancer Center · Tests: Busulfan, Cladribine, Fludarabine Phosphate, Hematopoietic Cell Transplantation, Thiotepa Individualized AML Treatment NCT07613385n/a1 site📍 Duarte City of Hope Medical Center · Tests: Observational Novel Digital Application for Patients With Acute Leukemia NCT06472128NA3 sites📍 Boston📍 Durham📍 Seattle Massachusetts General Hospital · Tests: DREAMLAND, VITAL WELLNESS Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation NCT06247501Phase 21 site📍 Seoul Seoul National University Hospital · Tests: SNUH-CD19-CAR-T MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome NCT07582172Phase 21 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Echocardiography Test, Fludarabine Phosphate Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol NCT06764238Phase 2, Phase 327 sites📍 Hefei📍 Hefei📍 Fuzhou Institute of Hematology & Blood Diseases Hospital, China · Tests: Blinatumomab (Group A), Venetoclax (nonRand Group), Blinatumomab (Group B) HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML NCT06594445Phase 11 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: GTB-360 Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells NCT07220993Phase 12 sites📍 Houston📍 Houston Baylor College of Medicine · Tests: CD7.CAR/28zeta T Cells Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR NCT02416388Phase 2, Phase 356 sites📍 Amiens📍 Angers📍 Argenteuil University Hospital, Angers · Tests: Idarubicin, Daunorubicin, HD Cytarabine, Cyclosporine, Methotrexate Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome NCT01311258n/a1 site📍 Rochester University of Rochester Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy NCT03630991Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Edetate Calcium Disodium, Multivitamin, Succimer SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) NCT03113643Phase 13 sites📍 Duarte📍 Boston📍 Houston Dana-Farber Cancer Institute · Tests: Azacitidine, SL-401, Venetoclax 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome NCT06287944Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Actinium Ac 225-DOTA-Daratumumab, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomograp… A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe. NCT07301866Phase 1, Phase 21 site📍 Montreal Ciusss de L'Est de l'Île de Montréal · Tests: ECT-001-CB Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia NCT06869265Phase 21 site📍 Beijing Peking University People's Hospital · Tests: Thiotepa ;busulfan;fludarabine First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS) NCT07384715Phase 16 sites📍 Aarhus📍 Copenhagen📍 Barcelona Genmab · Tests: GEN3018 Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies NCT07044544Phase 11 site📍 Birmingham University of Alabama at Birmingham · Tests: G-CSF, Decitabine, Venetoclax Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders NCT04644016Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Clofarabine, Fludarabine, Busulfan, Cyclosporine-A, Mycophenolate Mofetil Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome NCT03661307Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Decitabine, Quizartinib, Venetoclax
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy